ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.3236G>A (p.Arg1079Gln)

gnomAD frequency: 0.00002  dbSNP: rs727504342
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000154461 SCV000204130 uncertain significance not specified 2019-07-03 criteria provided, single submitter clinical testing The p.Arg1079Gln variant in MYH7 has been identified in 3 individuals with cardiomyopathy (1 with DCM and 2 with HCM) and segregated with disease in one affected family member (Waldmüller 2011, Cecconi 2016, LMM data). In addition, this variant was identified by our laboratory in 1 individual with HCM and 1 affected family member, who both also carried a pathogenic variant in MYBPC3. This variant has been identified in 2/129124 of European chromosomes by gnomAD (http://gnomad.broadinstitute.org) and has been reported in ClinVar (Variation ID:177826). Computational prediction tools and conservation analysis suggest that the p.Arg1079Gln variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Arg1079Gln variant is uncertain. ACMG/AMP Criteria applied: PM2, PS4_Supporting, BP4.
Agnes Ginges Centre for Molecular Cardiology, Centenary Institute RCV000172886 SCV000223876 uncertain significance Hypertrophic cardiomyopathy 1 2017-04-10 criteria provided, single submitter research This MYH7 Arg1079Gln variant is a rare occurrence in the general population; it is not observed in the 1000 genomes project (http://www.1000genomes.org/), and is a singleton event in the Exome Aggregation Consortium dataset (MAF= 0.000008, http://exac.broadinstitute.org/). We have identified the MYH7 Arg1079Gln variant in an HCM proband where two additional MYBPC3 variants have also been observed in the family (Girolami F, et al., 2010). One of the additional variants (MYBPC3 Gln969Ter) is well described as disease-causing. Segregation analysis showed this MYH7 Arg1079Gln variant to be present in one other affected family member (who also carries the disease causative MYBPC3 Gln969Ter variant). The MYH7 Arg1079Gln has been identified in a general population (Bick AG, et al., 2012) and 2 HCM probands (Alfares AA et al., 2015; Cecconi M et al., 2016), no further evidence is provided in these studies to support a pathogenic role. This variant has also been identified in one DCM patient (Waldmüller S, et al., 2011) and double heterozygous amyloidosis with HCM case (Ebrille E, et al., 2013). Predictions from in silico tools are contradictory with SIFT and MutationTaster predicting the amino acid substitution to be "deleterious" and "disease-causing". PolyPhen-2 predicts the impact of this variant to be "benign" (note: no prediction is made by PolyPhen-HCM). Due to limited segregation analysis due to small number of informative individuals, and co-occurrence with a MYBPC3 variant that explains the disease phenotype, we classify this MYH7 Arg1079Gln variant as one of "uncertain significance".
Invitae RCV000803421 SCV000943292 uncertain significance Hypertrophic cardiomyopathy 2023-11-02 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1079 of the MYH7 protein (p.Arg1079Gln). This variant is present in population databases (rs727504342, gnomAD 0.002%). This missense change has been observed in individual(s) with dilated cardiomyopathy and/or hypertrophic cardiomyopathy (PMID: 20359594, 21750094, 24749114, 25611685, 27532257, 27600940, 28790153; Invitae). ClinVar contains an entry for this variant (Variation ID: 177826). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYH7 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001171207 SCV001333909 uncertain significance Cardiomyopathy 2017-11-08 criteria provided, single submitter clinical testing
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV001197489 SCV001368255 uncertain significance Congenital myopathy with fiber type disproportion 2019-09-22 criteria provided, single submitter clinical testing This variant was classified as: Uncertain significance. The available evidence favors the pathogenic nature of this variant, however the currently available data is insufficient to conclusively support its pathogenic nature. Thus this variant is classified as Uncertain significance - favor pathogenic. The following ACMG criteria were applied in classifying this variant: PM2.
Color Diagnostics, LLC DBA Color Health RCV001171207 SCV002051925 uncertain significance Cardiomyopathy 2022-12-06 criteria provided, single submitter clinical testing This missense variant replaces arginine with glutamine at codon 1079 of the MYH7 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in several unrelated individuals affected with hypertrophic cardiomyopathy (PMID: 25611685, 27600940, 27532257, 33495597), dilated cardiomyopathy (PMID: 21750094), or systemic amyloidosis with a cardiac involvement (PMID: 24749114). This variant has also been reported in two families with hypertrophic cardiomyopathy, including three affected carriers and three unaffected carriers (PMID: 20359594, 28687478, 28790153). This variant has been identified in 2/282774 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.